BH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT' | BMC medical ethics |  | 2023 | 41 | 3 | ||
| Universal test and treat and the HIV epidemic in rural South Africa : a phase 4, open-label, community cluster randomised trial | The lancet. HIV | | 2018 | 27 | 10 | ||
| Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa? | Frontiers in Microbiology | | 2017 | 533 | 183 | ||
| The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events | Journal of acquired immune deficiency syndromes |  | 2016 | 39 | 0 | ||
| Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort Study | Open forum infectious diseases | | 2016 | 37 | 6 | ||
| Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal | BMC public health | | 2015 | 42 | 4 | ||
| Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study | European journal of clinical investigation |  | 2015 | 546 | 0 | ||
| HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons | BMC gastroenterology | | 2015 | 36 | 5 | ||
| Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence | Lancet | | 2015 | 634 | 0 | ||
| Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV | International journal of epidemiology | | 2014 | 663 | 408 | ||
| Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone | HIV clinical trials | | 2014 | 39 | 0 | ||
| Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence : the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa : study protocol for a cluster randomised controlled trial | Trials | | 2013 | 46 | 4 | ||
| The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients | PLoS computational biology | | 2013 | 615 | 220 | ||
| Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study | Neurology | | 2013 | 665 | 1 | ||
| Capnocytophaga canimorsus prosthetic aortitis in an HIV-positive woman | Journal of clinical microbiology | | 2013 | 651 | 265 | ||
| Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid | Journal of acquired immune deficiency syndromes and human retrovirology | | 2013 | 500 | 0 | ||
| The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study | Antiviral therapy | 2013 | 677 | 0 | |||
| Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field | PloS one | | 2013 | 643 | 1 120 | ||
| Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity* | HIV medicine | | 2012 | 563 | 1 | ||
| Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia | AIDS | | 2012 | 614 | 0 | ||
| Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | | 2012 | 703 | 300 | ||
| Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations | Clinical infectious diseases | | 2012 | 992 | 236 | ||
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | | 2012 | 653 | 0 | ||
| Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections | AIDS | | 2012 | 684 | 399 | ||
| Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B | Clinical infectious diseases | | 2011 | 534 | 367 | ||
| Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection | Clinical infectious diseases | | 2011 | 827 | 719 | ||
| Severe leptospirosis with multiple organ failure successfully treated by plasma exchange and high-volume hemofiltration | Case Reports in Nephrology and Dialysis | | 2011 | 420 | 152 | ||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | 2011 | 954 | 553 | ||
| Ageing with HIV : medication use and risk for potential drug-drug interactions | Journal of antimicrobial chemotherapy | | 2011 | 25 | 0 | ||
| Successful efavirenz dose reduction guided by therapeutic drug monitoring | Antiviral therapy | | 2011 | 18 | 0 | ||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | 2011 | 787 | 8 | ||
| Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study | HIV medicine | | 2011 | 555 | 0 | ||
| Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection | Gut | | 2011 | 610 | 0 | ||
| VIH/SIDA : nombreuses nouveautés | Revue médicale suisse | | 2011 | 34 | 25 | ||
| Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study | Journal of translational medicine | | 2011 | 607 | 278 | ||
| The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland | The Journal of infectious diseases | | 2011 | 610 | 580 | ||
| Human herpes virus type 8 seroprevalence in pregnant women in Geneva, Switzerland | Journal of maternal-fetal & neonatal medicine | | 2011 | 603 | 0 | ||
| Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors | Journal of acquired immune deficiency syndromes | | 2011 | 636 | 1 578 | ||
| No Longitudinal Mitochondrial DNA Sequence Changes in HIV-infected Individuals With and Without Lipoatrophy | Scandinavian journal of infectious diseases | | 2011 | 802 | 92 | ||
| HIV treatment for prevention | Journal of the International AIDS Society | | 2011 | 42 | 9 | ||
| Clinical relevance of cytomegalovirus viraemia | HIV medicine | | 2011 | 583 | 0 | ||
| Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy | Gut | | 2010 | 568 | 0 | ||
| Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | | 2010 | 524 | 0 | ||
| Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir | AIDS | | 2010 | 562 | 0 | ||
| Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections | The Journal of infectious diseases | | 2010 | 567 | 0 | ||
| "Swiss statement": bilan deux ans après | Revue médicale suisse | 2010 | 510 | 0 | |||
| Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland | The Journal of infectious diseases | | 2010 | 530 | 0 | ||
| Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load | PLOS pathogens | | 2010 | 624 | 445 | ||
| HIV drugs for treatment, and for prevention | Lancet | | 2010 | 554 | 0 | ||
| Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report | Journal of medical case reports | | 2010 | 650 | 282 | ||
| Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors | International journal of infectious diseases | | 2010 | 541 | 0 | ||
| Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia | Clinical infectious diseases | | 2010 | 542 | 0 | ||
| Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals | Clinical infectious diseases | | 2010 | 571 | 0 | ||
| Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study | Clinical infectious diseases | | 2010 | 559 | 0 | ||
| CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2 | Journal of acquired immune deficiency syndromes | | 2010 | 549 | 0 | ||
| Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 | Archives of internal medicine | | 2010 | 491 | 0 | ||
| Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures | Journal of acquired immune deficiency syndromes | | 2010 | 581 | 0 | ||
| No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial | HIV medicine | | 2010 | 504 | 0 | ||
| Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection | Clinical infectious diseases | | 2010 | 481 | 0 | ||
| Cognitive dysfunction in HIV patients despite long-standing suppression of viremia | AIDS | | 2010 | 867 | 1 | ||
| Health perceptions of African HIV-infected patients and their physicians | Patient education and counseling | | 2010 | 560 | 0 | ||
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Gastroenterology | | 2010 | 804 | 0 | ||
| A new era of antiretroviral drug toxicity | Antiviral therapy | 2009 | 518 | 0 | |||
| Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy | Journal of clinical epidemiology | | 2009 | 454 | 0 | ||
| Cas importés d'histoptasmose | Revue médicale suisse | 2009 | 577 | 0 | |||
| Is it smart to continue to study treatment interruptions? | AIDS | | 2009 | 517 | 0 | ||
| Nouveau spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapies | Revue médicale suisse | 2009 | 516 | 0 | |||
| Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study | HIV medicine | | 2009 | 456 | 0 | ||
| Education thérapeutique en maladie infectieuse : l'exemple de l'infection à VIH | Revue médicale suisse | 2009 | 569 | 0 | |||
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | | 2009 | 605 | 0 | ||
| The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection | AIDS | | 2009 | 519 | 0 | ||
| Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples | Sexually transmitted infections | | 2009 | 537 | 0 | ||
| VIH-sida | Revue médicale suisse | 2009 | 409 | 0 | |||
| Safety and efficacy of once-daily nevirapine dosing: a multicohort study | Antiviral therapy | 2009 | 599 | 0 | |||
| How reliable is an undetectable viral load? | HIV medicine | | 2009 | 512 | 0 | ||
| Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine : a nested case-control study | Clinical infectious diseases | | 2009 | 19 | 0 | ||
| Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 | PloS one | | 2009 | 1 052 | 771 | ||
| Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure | Hepatology | | 2009 | 548 | 0 | ||
| Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study | Antiviral therapy | 2009 | 440 | 0 | |||
| Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case report | Journal of medical case reports | | 2009 | 581 | 561 | ||
| Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals | HIV clinical trials | 2009 | 478 | 0 | |||
| Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland | Clinical infectious diseases | | 2009 | 569 | 0 | ||
| Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study | Circulation. Cardiovascular genetics | | 2009 | 483 | 0 | ||
| Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV | Antiviral therapy | 2009 | 523 | 0 | |||
| The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients | The Open AIDS journal | | 2009 | 599 | 340 | ||
| Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study | The Journal of infectious diseases | | 2009 | 540 | 0 | ||
| HIV transmission under highly active antiretroviral therapy | Lancet | | 2008 | 552 | 0 | ||
| Antiretroviral treatment during pregnancy | AIDS | | 2008 | 606 | 0 | ||
| Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir | Clinical infectious diseases | | 2008 | 511 | 0 | ||
| Dix ans de lipodystrophie (1998-2008) : un syndrome encore méconnu | Revue médicale suisse | | 2008 | 509 | 79 | ||
| Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen | AIDS | | 2008 | 503 | 0 | ||
| Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study | HIV medicine | | 2008 | 528 | 0 | ||
| Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study | The Journal of infectious diseases | | 2008 | 575 | 0 | ||
| Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir | Antiviral therapy | | 2008 | 487 | 0 | ||
| Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy | British journal of cancer | | 2008 | 542 | 0 | ||
| Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure | The Open virology journal | | 2008 | 618 | 718 | ||
| Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study | HIV medicine | | 2008 | 578 | 0 | ||
| Preference for CD4-guided versus continuous HARRT in Thailand | AIDS care | 2008 | 500 | 0 | |||
| Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection | AIDS | | 2008 | 578 | 0 | ||
| The Monark trial: where now for boosted protease inhibitor monotherapy? | AIDS | | 2008 | 519 | 0 | ||
| PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnelles | Revue médicale suisse | 2008 | 448 | 0 | |||
| Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting | International journal of STD & AIDS | 2008 | 553 | 0 | |||
| Initial treatment for HIV infection--an embarrassment of riches | The New England journal of medicine | | 2008 | 558 | 0 | ||
| HIV transmission hunting--the chase for low risk events | Antiviral therapy | | 2008 | 469 | 0 | ||
| Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era | AIDS | | 2008 | 580 | 0 | ||
| HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy | Clinical infectious diseases | | 2008 | 480 | 0 | ||
| Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study | Antiviral therapy | | 2008 | 351 | 0 | ||
| Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy | The journal of antimicrobial chemotherapy | | 2008 | 561 | 0 | ||
| HIV rebounds from latently infected cells, rather than from continuing low-level replication | Proceedings of the National Academy of Sciences of the United States of America | | 2008 | 541 | 0 | ||
| Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients | Antiviral therapy | | 2008 | 482 | 0 | ||
| Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection | The New England journal of medicine | | 2008 | 597 | 0 | ||
| Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006 | HIV medicine | | 2008 | 550 | 0 | ||
| CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy | Clinical infectious diseases | | 2008 | 554 | 0 | ||
| Ferritin levels during structured treatment interruption of highly active antiretroviral therapy | HIV medicine | | 2007 | 441 | 0 | ||
| Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy | Pharmacogenetics and genomics | | 2007 | 572 | 0 | ||
| Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score | AIDS | | 2007 | 467 | 0 | ||
| Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression | Journal of virology | | 2007 | 500 | 0 | ||
| Clinical update: adverse effects of antiretroviral therapy | Lancet | | 2007 | 583 | 0 | ||
| Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study | Antiviral therapy | | 2007 | 513 | 0 | ||
| Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study | AIDS | | 2007 | 538 | 0 | ||
| HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy | Journal of internal medicine | | 2007 | 520 | 0 | ||
| No patient left behind--better treatments for resistant HIV infection | Lancet | | 2007 | 522 | 0 | ||
| VIH – sida Traitement de l'infection à VIH en 2006 : points forts | Revue médicale suisse | 2007 | 498 | 0 | |||
| Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study | HIV clinical trials | | 2007 | 526 | 0 | ||
| No change in calculated creatinine clearance after tenofovir initiation among Thai patients | The journal of antimicrobial chemotherapy | | 2007 | 472 | 0 | ||
| Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study | Clinical infectious diseases | | 2007 | 460 | 0 | ||
| Treatment interruption for convenience, cost cutting and toxicity sparing | Current opinion in HIV and AIDS | | 2007 | 506 | 0 | ||
| HIV viral load monitoring in resource-limited regions: optional or necessary? | Clinical infectious diseases | | 2007 | 563 | 1 | ||
| Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission | Clinical infectious diseases | | 2007 | 523 | 0 | ||
| Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types | Archives of internal medicine | | 2007 | 522 | 0 | ||
| Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study | Antiviral therapy | | 2007 | 468 | 0 | ||
| CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy | Antiviral therapy | | 2007 | 472 | 0 | ||
| Review on structured treatment interruptions (STIs) | Topics in HIV medicine | | 2007 | 379 | 0 | ||
| Intermittent therapy for the treatment of chronic HIV infection | AIDS | | 2007 | 519 | 0 | ||
| Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy | Antiviral therapy | | 2007 | 521 | 0 | ||
| The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial | AIDS | | 2007 | 558 | 0 | ||
| Late presentation of HIV-infected individuals | Antiviral therapy | | 2007 | 476 | 0 | ||
| The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load | Archives of internal medicine | | 2007 | 439 | 0 | ||
| Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification | Antiviral therapy | | 2007 | 519 | 1 | ||
| Increased incidence of sexually transmitted infections in Geneva, Switzerland | Dermatology |